Biotech

All Articles

Novartis kindles brand-new stage of Voyager treaty along with $15M capsid bargain

.Novartis levels a brand new outpost in its own cooperation along with Voyager Rehabs, paying $15 th...

Lilly messages more beneficial information on its own once a week insulin possibility

.On the heels of an FDA turndown for its own primary competing Novo Nordisk, Eli Lilly is pushing on...

IN 8bio stops stage 2 test, lays off half of labor force

.Merely a few months after dosing the very first patient in a period 2 test for newly detected gliob...

Lilly, Haya ink $1B biobuck weight problems treaty to browse dark genome

.Eli Lilly's search for excessive weight intendeds has led it to the dark genome. The Big Pharma has...

ArsenalBio elevates $325M, pivots out of former lead property

.Collection Biosciences is moving on up. The cell treatment company has actually added $325 thousand...

Lilly- backed weight reduction biotech documents IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' marijuana use medicine fails stage 2b, steering Indivior to re-think $100M alternative

.Aelis Farma's hopes of safeguarding a simple, beneficial choice on a $one hundred million choice re...

ProKidney standstills phase 3 test not required for tissue therapy approval

.ProKidney has quit among a pair of period 3 tests for its cell treatment for kidney disease after d...

Vaxcyte climbs on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what professionals named "stunning" phase 1/2 records for its own 31-valent pneumo...

Recursion's brain disease trial reveals insufficient proof of efficiency

.Recursion has discovered via a very early test of its tech-enabled technique to medicine discovery,...